Assignee
AGENDIA N V
NL·1 granted patent·4 pending applications·6 citations·filing 2015–2023
Top patents by PatentIndex Score
5 records- 0180US10072301B2Means and methods for molecular classification of breast cancerAGENDIA N V·Filed 2015·Granted Sep 11, 2018·6 cites·14 claims
- 0256US2026049359A1Prediction of response to immune therapy in breast cancer patientsAGENDIA N V·Filed 2023·Application pending·0 cites
- 0352US2025011873A1Endocrine treatment of hormone receptor positive breast cancer typed as having a low risk of recurrenceAGENDIA N V·Filed 2022·Application pending·0 cites
- 0447US2017292162A1Method and Means for Typing a Sample Comprising Cancer Cells Based on Oncogenic Signal Transduction PathwaysAGENDIA N V·Filed 2017·Application pending·0 cites
- 0546US2023330223A1Treatment of her2 negative, mammaprint high risk 2 breast cancerAGENDIA N V·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AGENDIA N V files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →